TRON Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development of oral, topical, and injectable products for cancer, central nervous system disorders, and infectious diseases. The company was founded on October 20, 2015 and is headquartered in Alachua, FL.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company